Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

FY27-28 Pediatric Flu Vaccines

Active
75D30126R73518Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → CDC Office Of Acquisition ServicesView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Atlanta, GA, 30329, USA

Set-Aside

NONE

Documents

(6)

A19+D-1+ADR+Pediatric.docx

DOCX

A19+75D30126R73518+FY27-28+Peditatric+Flu+Sol..docx

DOCX

A19+D-2+List+of+Products.docx

DOCX

A19+-+75D30126R73406+-+1449+Solicitation+Cover+Page+2021+version.pdf

PDF

A19+D-4+Public+Disclosure+and+Publication+of+Vaccine+Pricing.docx

DOCX

A19+D-3+AI+Use+Compliance+Risk+Management+Plan.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseCombined Synopsis
Posted

Combined Synopsis

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts2 people available
OfficeATLANTA, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
View Agency Profile
Office AddressATLANTA, GA, 30333, USA
Contacts

Full Description

Show more

The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines.  Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children.  The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage.  Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act).  Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program.  The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace.  In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds.



Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. § 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Health And Human Services → CDC Office Of Acquisition Services

Same awarding agency

NAICS: 541511
New
Federal
Modernized VAERS Reporting Application
Solicitation # 75D301-26-Q-00146
The Centers for Disease Control and Prevention is seeking a contractor to design, develop, and deliver a modernized, responsive web application for the Vaccine Adverse Event Reporting System (VAERS). The project focuses on improving the reporting experience for both the public and healthcare providers through a redesigned landing page, a guided reporting workflow with branching logic, and a low-code interface for CDC personnel to make updates. Key performance targets include page load times of 3 seconds or less, a median end-to-end submission time of 10 minutes or less, and a 30 percent reduction in submission abandonment. The application will operate within the CDC-managed MS Azure cloud environment and must comply with federal standards including HIPAA, FISMA, FedRAMP, and Section 508 accessibility guidelines. This firm-fixed-price contract has a period of performance from September 28, 2026, to June 27, 2027, with an estimated not-to-exceed value of 31,500 dollars. Award will be based on a best value tradeoff process where technical approach, management approach, and similar experience are significantly more important than price. Contractors must adhere to strict security and privacy protocols, including the handling of Controlled Unclassified Information and the submission of an Artificial Intelligence Use Compliance and Risk Management Plan if AI is utilized. Performance is primarily remote within the United States, requiring routine coordination with CDC personnel in Atlanta, Georgia.
Custom Computer Programming Services

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 541380
New
Federal
Scalable Wastewater Surveillance for Routine and Emerging Infectious Disease Pathogens
Solicitation # 75D301-26-R-73493
The Centers for Disease Control and Prevention (CDC) has issued solicitation 75D301-26-R-73493 for a single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract titled Scalable Wastewater Surveillance for Routine and Emerging Infectious Disease Pathogens. This contract establishes a flexible mechanism to support ongoing wastewater surveillance, rapid response to emerging infectious disease threats, and public health emergency preparedness. The IDIQ has a maximum value of 145 million dollars with a minimum guarantee of 10,000 dollars and an ordering period spanning from September 15, 2026, to September 14, 2031. Under Task Order 1, the contractor is required to establish testing services for up to 200 public wastewater treatment facilities across the United States, its territories, and tribal lands. The scope includes providing sampling and shipping kits, training facility staff on collection and transport, and performing ddPCR testing for pathogens such as IAV H3, IAV H5, IBV, RSV, SARS-CoV-2, and Wild Type Measles, with specific volumes reaching up to 20,800 samples per pathogen. The period of performance for this initial task order is from September 15, 2026, to September 14, 2027, with a possible six-month extension. The contract is awarded based on a best value tradeoff process, where technical factors—including technical, staffing, and management approaches and similar experience—are significantly more important than price. Contractors must adhere to strict data security standards, including NIST SP 800-53 and 800-171 for handling Controlled Unclassified Information. Additionally, any use of artificial intelligence in contract performance requires a formal Compliance and Risk Management Plan to ensure ethical standards and prevent unlawful discrimination. Administrative requirements include electronic invoicing via the Department of Treasury Invoice Processing Platform and the submission of a comprehensive subcontracting plan covering various small business categories.
Testing Laboratories and Services

POSTED

2 days ago

DEADLINE

in about 3 hours
View Details
NAICS: 562112
New
Federal
NIOSH Hazardous Waste Services
Solicitation # 75D301-26-R-73423
The CDC Office of Acquisition Services is soliciting a firm-fixed-price contract for comprehensive hazardous and toxic waste disposal services to support NIOSH sites in Cincinnati, Ohio; Morgantown, West Virginia; Pittsburgh, Pennsylvania; and Spokane, Washington. The contractor is responsible for the pickup, transportation, labeling, analysis, and ultimate treatment or disposal of hazardous chemical waste, universal waste, and additional waste streams such as used oils and charcoal filters. Services include one pickup per location each calendar quarter, with a requirement to return modified waste tracking documents linking NIOSH item numbers to RCRA waste codes within 60 days of pickup. The contract consists of a base period from August 7, 2026, to August 6, 2027, and an option period extending to August 6, 2028. All operations must strictly adhere to U.S. DOT regulations under 49 CFR Parts 100-199 for transportation and 40 CFR 261 and 264/265 for waste definition and disposal. The government will utilize a Lowest Price Technically Acceptable (LPTA) source selection process, awarding the contract to the responsible offeror with an acceptable technical rating and the lowest evaluated price. Contractors must provide all necessary personnel, equipment, and supplies, and are required to ensure all employees sign a CDC Non-Disclosure Agreement before commencing work. Payment will be processed electronically via the Department of Treasury Invoice Processing Platform.
Hazardous Waste Collection

POSTED

6 days ago

DEADLINE

in 2 days
View Details